1) Conclusion: As a treatment for appropriate patients with mitral stenosis, PBMV has good long - term results.

2) Combination of simple mitral stenosis and mitral incompetence can breakdown the risk for formation of atria sinistrum mural thrombosis.

3) Conversely, a diminished or absent S1 in mitral stenosis suggests a rigidly calcified valve that cannot "snap" shut.

4) The abnormality mitral stenosis was in myocardium, not in the valve.

5) The hemostatic characteristics were studied in patients with mitral stenosis(MS) in an attempt to confirm the existence of the prethrombotic state(PTS) and to investigate its mechanism.

6) Objective To evaluate the effects of percutaneous balloon mitral valvotomy (PBMV) for mitral stenosis (MS) with moderate mitral regurgitation (MR), particularly with bad mitral condition.

7) The right ventricular function was studied before and after percutaneous balloon mitral valvuloplasty(PBMV) in 40 patients with rheumatic mitral stenosis.

8) Objective To analyse the related factors of left atrial thrombosis in patients with rheumatic mitral stenosis by echocardiography.

9) Objective:To conduct such a study on TSS downstream of mitral stenosis using a finite element model of two dimensions combined with Doppler echocardiography in human beings.

10) The interval between S2 and the OS is related to the severity of mitral stenosis. The more severe the stenosis, the shorter the S2-OS interval.

11) Objective:To evaluate the safety and efficacy of percutaneous balloon mitral valvuloplasty(PBMV) in patients with rheumatic severe mitral stenosis and thrombus in the left atrial appendage.

12) Conclusion The pathological shortening of mitral valve and sub-valvular apparatus caused by long-term rheumatic disease is the main cause of decreased left ventricular volume in mitral stenosis.

13) Objective To explore new method of percutaneous balloon serious mitral stenosis commissurotomy.

14) Analysis of the effects by percutaneous mitral balloon valvuloplasty in rheumatic mitral stenosis.

15) Conclusions PMMC is an efficient,[http:///mitral stenosis.html] safe and economic method to theraphy the mitral stenosis with bad valvular condition.

16) Methods The study group consisted of 145 patients with rheumatic mitral stenosis (MS) underwent TTE before and after PBMV. Mitral valve area (MVA) and left atrial pressure (LAP) were measured by TTE.

17) Conclusion Lutembacher's syndrome should be treated surgically and promptly. Repairing ASD and well-management of mitral stenosis and tricuspid regurgitation, could harvest satisfactory consequence.

18) Objective To observe safty and effect of percutaneous balloon mitral valvuloplasty(PBMV) on the patients with rheumatic mitral stenosis complicated with left atrial thrombus.

19) Objective To evaluate the effects of percutaneous balloon mitral valvotomy (PBMV) for mitral stenosis (MS) with mitral regurgitation (MR).

20) Objective To assess efficacy of percutaneous balloon mitral valvotomy (PBMV) with an Inoue balloon catheter in the treatment of mitral stenosis with high pulmonary hypertension.

21) Objective To study the relationship between the degree of mitral stenosis (MS) and atrial filling fraction (AFF).

22) Objective:To observe whether percutaneous transluminal ballonmitral valvuloplasty (PTBMV) can improve the pulmonary function of patients with single mitral stenosis (MS).

23) Conclusions RT3DE provides a simple, exact and reliable approach in the quantification of mitral stenosis.

24) Objective : To analyze the characteristics and occurrence of silent mitral stenosis ( SMS ) in rheumatic heart disease.

25) Objective To compare the differences of mitral valve replacement between preservation and no preservation of subvalvular apparatuses for severe mitral regurgitations with mitral stenosis.